Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2011 | 06-2011 | 12-2010 | 06-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 900 | N/A | 0 | N/A |
| Depreciation Amortization | N/A | 610 | N/A | 0 | N/A |
| Other Working Capital | N/A | -90 | N/A | 0 | N/A |
| Other Operating Activity | 0 | 810 | 0 | -3,790 | 0 |
| Operating Cash Flow | $N/A | $2,230 | $N/A | $-3,790 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 5 | N/A | -960 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 50 | 0 |
| Investing Cash Flow | $N/A | $5 | $N/A | $-910 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -310 | 0 | 690 | 0 |
| Financing Cash Flow | $N/A | $-310 | $N/A | $690 | $N/A |
| Exchange Rate Effect | N/A | -120 | N/A | 30 | N/A |
| Beginning Cash Position | N/A | 3,300 | N/A | 6,900 | N/A |
| End Cash Position | N/A | 5,100 | N/A | 2,910 | N/A |
| Net Cash Flow | $N/A | $1,790 | $N/A | $-3,980 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 2,230 | N/A | -3,790 | N/A |
| Free Cash Flow | 0 | 2,230 | 0 | -3,790 | 0 |